BioPhotas has announced the launch of the light therapy device, Celluma CONTOUR, designed for body contouring, treating ageing skin, and managing pain.
The device received clearance from the US Food and Drug Administration (FDA).
Related: Empatica officially launches wearable epilepsy monitoring watch EpiMonitor
The technology behind the Celluma CONTOUR is based on an algorithm that optimises light energy delivery. This process not only decreases the fat stored in adipose tissue but also contributes to a slimmer waist, hips and thighs, enhancing the skin’s overall appearance.
An observational study showed participants losing an average of two inches after using CONTOUR for 30 minutes, three times a week over four weeks, without altering their diet or exercise habits.
BioPhotas president and CEO Curtis Cluff said: “The Celluma CONTOUR is the first LED Light Therapy device to be FDA-cleared on an over-the-counter basis for body contouring.
“It is also the only LED light therapy device on the market designed with multiple treatment modes for reducing wrinkles, reducing muscle and joint pain, as well as body contouring in a single device.”
Available as a three-panel set, the Celluma CONTOUR allows simultaneous treatment of the waist, hips, and thighs within a 30-minute session.
Additionally, customers have the option to purchase a single panel for targeted treatment areas.
For a comprehensive whole-body therapy, the Celluma DELUX and DELUX XL models now include a body contouring mode, alongside the existing pain management and anti-ageing functions.
Cluff added: “With the development of the CONTOUR, Celluma Light Therapy firmly establishes itself as the leader in whole-body wellness, with non-toxic, non-invasive, FDA-cleared devices treating everything from body contouring to hair loss, acne, ageing skin, and general pain conditions.
“Like all Celluma devices, the CONTOUR is made with our patented, flexible, shape-taking design that can be easily shaped around any part of the body and made to fit all different body types.”
